IL105474A0 - Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis - Google Patents

Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis

Info

Publication number
IL105474A0
IL105474A0 IL105474A IL10547493A IL105474A0 IL 105474 A0 IL105474 A0 IL 105474A0 IL 105474 A IL105474 A IL 105474A IL 10547493 A IL10547493 A IL 10547493A IL 105474 A0 IL105474 A0 IL 105474A0
Authority
IL
Israel
Prior art keywords
dehydrovitamin
1alpha
dihydroxy
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL105474A
Other languages
English (en)
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of IL105474A0 publication Critical patent/IL105474A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
IL105474A 1992-04-24 1993-04-21 Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis IL105474A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87338992A 1992-04-24 1992-04-24

Publications (1)

Publication Number Publication Date
IL105474A0 true IL105474A0 (en) 1993-08-18

Family

ID=25361550

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105474A IL105474A0 (en) 1992-04-24 1993-04-21 Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis

Country Status (5)

Country Link
US (1) US5393749A (fr)
EP (1) EP0567353A1 (fr)
JP (1) JP3014241B2 (fr)
KR (2) KR960013798B1 (fr)
IL (1) IL105474A0 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
IL110117A0 (en) * 1994-06-24 1994-10-07 Univ Ben Gurion Pharmaceutical compositions comprising vitamin-d analogs
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
US5962707A (en) * 1998-08-18 1999-10-05 Wisconsin Alumni Research Foundation 19-nor-vitamin D3 compounds with calcemic activity
AU2001228330A1 (en) * 2000-01-31 2001-08-14 Leo Pharma A/S Vitamin d-derivatives and their use in treating osteoporosis and related bone disorders
WO2001056981A1 (fr) * 2000-01-31 2001-08-09 Leo Pharma A/S Utilisation de derives de vitamine d dans le traitement de l'osteoporose et de maladies osseuses associees, et nouveaux derives de vitamine d3
EP2393494A1 (fr) * 2009-01-27 2011-12-14 Berg Biosystems, LLC Vitamines d3 et analogues de celles-ci pour soulagement des effets secondaires associés à une chimiothérapie
CA2770683C (fr) 2009-08-14 2018-09-04 Berg Biosystems, Llc Vitamine d3 et ses analogues pour le traitement de l'alopecie
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4255596A (en) * 1980-02-25 1981-03-10 Gulf Research & Development Company Preparation of ethylene glycol from ethylene
JPS6089422A (ja) * 1983-10-24 1985-05-20 Kureha Chem Ind Co Ltd 抗骨粗鬆症剤
US4689180A (en) * 1984-01-30 1987-08-25 Wisconsin Alumni Research Foundation 1α,25-dihydroxy-22Z-dehydroxyvitamin D compound
US4719204A (en) * 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4822609A (en) * 1984-12-21 1989-04-18 The Procter & Gamble Company Treatment of osteoporosis
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
CA2010982C (fr) * 1989-02-28 2000-06-13 Toshio Matsumoto Promotion de l'osteogenese par l'utilisation de derives de vitamine d

Also Published As

Publication number Publication date
KR940005276A (ko) 1994-03-21
KR100214194B1 (ko) 1999-08-02
US5393749A (en) 1995-02-28
KR960013798B1 (ko) 1996-10-10
JPH069405A (ja) 1994-01-18
EP0567353A1 (fr) 1993-10-27
JP3014241B2 (ja) 2000-02-28

Similar Documents

Publication Publication Date Title
HUP9802086A3 (en) Pharmaceutical composition for piperidinoalkanol compounds
IL110421A0 (en) Pharmaceutical compositions for treating supraventricular tachyarrhythmias
HUP9603494A3 (en) Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof
SI0817621T1 (en) Pharmaceutical composition for transdermic delivery
HUP9601419A2 (en) Synergetic pharmaceutical compositions for treating parkinson-disease
HUP9900645A3 (en) Novel substituted imidazole compounds, pharmaceutical compositions containing them and process for their producing
HU9500229D0 (en) Pharmaceutical composition against osteoporosis
HUP0002050A3 (en) Substituted imidazole compounds, process for producing them, pharmaceutical compositions containing them and their use
HUP9802705A3 (en) Aromatic compounds process for producing them and pharmaceutical compositions containing them
HUP9601034A3 (en) Aryl-alkyl-pyridazinone compounds, process for producing them, and pharmaceutical compositions containing them
IL118590A (en) Pharmaceutical composition for minimizing bone loss
IL105474A0 (en) Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis
HU9303113D0 (en) Pharmaceutical compositions containing 1,2-dithiol-3-thione-derivatives
SG43083A1 (en) Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
IL108197A0 (en) Pharmaceutical composition for preventing or treating arterioscleriosis
ZA931593B (en) 2,4-Thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them.
HUP0000952A3 (en) Carbapenem compounds, process for their preparation and pharmaceutical compositions containing them
HUT76129A (en) Arthropocidal compounds, compositions containing them and process for their preparation
HUP9601976A3 (en) 4-fluoralkyl benzoylguanidines, process for producing them and pharmaceutical compositions containing these compounds
HUP9702481A3 (en) New n-benzylpiperazine compounds, process for producing them and the pharmaceutical compositions which containing them
AU7295696A (en) Pharmaceutical composition for treating osteoporosis
HU9503422D0 (en) New compounds, pharmaceutical compositions containing them and process for producing them
IL95245A0 (en) Pharmaceutical compositions containing a certain carbazolone for the treatment of bulimia
IL106763A0 (en) Pharmaceutical compositions for treating cancer